Capricor Therapeutics Inc (CAPR)

Cost of Revenue

$20.36M

TTM · Period ending: · USD

CAPR logo

CAPR Cost of Revenue

Latest reported$20.36M
CAPR TTM Cost of Revenue ($0.00 → $20.36M)
High-resolution chart · PNG

CAPR cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Capricor Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
20,359,098
42,406,352
61,321,924
75,876,860
67,325,629
57,783,144
49,968,585
45,353,816
33,545,949
21,041,180
9,940,167
0
0
4,965,088
10,080,787
14,344,320
16,858,235
11,893,147
6,777,448
5,259,019
5,374,371
7,301,844
8,457,000
6,540,645
3,911,378
1,983,905
828,749
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,223,278
2,223,278
2,223,278
2,223,278
0
0
0
0
937,922
1,261,325
1,261,325
1,261,325
323,403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.